TrialPloS one2022

Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial.

Silvia M Caceres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.